Efavirenz
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/958584/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/958584/Cv/1'> | ||
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is sold both by itself and in combination as efavirenz/emtricitabine/tenofovir. It is taken by mouth. See also [https://en.wikipedia.org/wiki/Efavirenz]. | Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is sold both by itself and in combination as efavirenz/emtricitabine/tenofovir. It is taken by mouth. See also [https://en.wikipedia.org/wiki/Efavirenz]. | ||
| + | |||
| + | <scene name='95/958584/Cv/3'>Structure of HIV-1 reverse transcriptase initiation complex core with efavirenz</scene> ([[7kjw]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 10:08, 28 March 2023
| |||||||||||
